On January 2, 2020 Bio-Techne Corporation (NASDAQ:TECH) reported that Chuck Kummeth, President and Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 3:00 p.m. PST (Press release, Bio-Techne, JAN 2, 2020, View Sourcenews/detail/169/bio-techne-to-present-at-the-38th-annual-j-p-morgan-healthcare-conference" target="_blank" title="View Sourcenews/detail/169/bio-techne-to-present-at-the-38th-annual-j-p-morgan-healthcare-conference" rel="nofollow">View Source [SID1234552648]). The conference will be held at the Westin St. Francis Hotel in San Francisco, CA. A live webcast of the presentation can be accessed via Bio-Techne’s Investor Relations website at View Source or through the following link View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!